甲状腺许特莱氏细胞腺瘤1例及相关文献分析
A Case Report of Türthle Cell Neoplasms and Related Literature Analysis
DOI: 10.12677/MD.2022.121004, PDF,   
作者: 满孝丽, 王 洋：延安大学附属医院，陕西 延安；李小宝*：延安大学附属医院，胃肠疝外科，陕西 延安
关键词: 甲状腺；许特莱氏细胞肿瘤；Hürthle Cell Neoplasms；The Thyroid Gland； Hutrey’s Cell Tumor； Hürthle Cell Neoplasms
摘要: 甲状腺许特莱氏细胞肿瘤(Hürthle cell neoplasms, HCNs)是甲状腺肿瘤的一种特殊类型。该疾病在临床上较为罕见，在诊断方面缺乏特异性，术中快速冰冻检查可提高该病检出率，最终确诊需要在术后进行石蜡切片检查，同时在治疗上目前提倡个体化治疗原则。本文就在临床所见1例做一报告。
Abstract: Hürthle cell neoplasms (HCNs) are a special type of thyroid tumor. This disease is rare in clinic and lacks specificity in diagnosis. Rapid intraoperative freezing examination can improve the detection rate of this disease, and the final diagnosis requires paraffin section examination after operation. Meanwhile, the principle of individual treatment is advocated in the treatment. In this article, we report one case observed in clinic.
文章引用：满孝丽, 王洋, 李小宝. 甲状腺许特莱氏细胞腺瘤1例及相关文献分析[J]. 医学诊断, 2022, 12(1): 17-20. https://doi.org/10.12677/MD.2022.121004

参考文献

[1] Lopez-Penabad, L., Chiu, A.C., Hoff, A.O., Schultz, P., Gaztambide, S., Ordoñez, N.G. and Sherman, S.I. (2003) Prognostic Factors in Patients with Hürthle Cell Neoplasms of the Thyroid. Cancer, 97, 1186-1194. [Google Scholar] [CrossRef] [PubMed]
[2] 张东伟, 杨维良, 秦华东. 甲状腺许特莱氏细胞肿瘤的研究现状[J]. 临床外科杂志, 2005(9): 587-588.
[3] 张新华, 杨觅, 孟奎, 金行藻. 甲状腺嗜酸细胞肿瘤15例临床病理和免疫组化研究[J]. 诊断病理学杂志, 2003(2): 14-16+73.
[4] Agarwal, S., Bychkov, A., Jung, C.K., et al. (2019) The Prevalence and Surgical Outcomes of Hürthle Cell Lesions in FNAs of the Thyroid: A Multi-Institutional Study in 6 Asian Countries. Cancer Cytopathology, 127, 181-191. [Google Scholar] [CrossRef] [PubMed]
[5] Wenter, V., Albert, N.L., Unterrainer, M., et al. (2021) Clinical Impact of Follicular Oncocytic (Hürthle Cell) Carcinoma in Comparison with Corresponding Classical Follicular Thyroid Carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 48, 449-460. [Google Scholar] [CrossRef] [PubMed]
[6] Sippel, R.S., Elaraj, D.M., Khanafshar, E., Zarnegar, R., Kebebew, E., Duh, Q.-Y. and Clark, O.H. (2008) Tumor Size Predicts Malignant Potential in Hürthle Cell Neoplasms of the Thyroid. World Journal of Surgery, 32, 702-707. [Google Scholar] [CrossRef] [PubMed]
[7] Besic, N., Hocevar, M., Zgajnat, J., et al. (2006) Aggressiveness of Therapy and Prognosis of Patients with Hurthle Cell Papillary Thyroid Carcinoma. Thyroid, 16, 67-72. [Google Scholar] [CrossRef] [PubMed]
[8] Grossman, R.F. andClark, O.H. (2017) Hürthle Cell Carcinoma. Cancer Control, 4, 13-17. [Google Scholar] [CrossRef] [PubMed]
[9] 卢焕全, 吴志明, 周景华. 甲状腺全切术结合131Ⅰ清甲治疗甲状腺嗜酸细胞肿瘤的效果观察[J]. 中国实用医药, 2019, 14(23): 22-24. [Google Scholar] [CrossRef] 
[10] Oluic, B., Paunovic, I., Loncar, Z., et al. (2017) Survival and Prognostic Factors for Survival, Cancer Specific Survival and Disease Free Interval in 239 Patients with Hurthle Cell Carcinoma: A Single Center Experience. BMC Cancer, 17, 1-11. [Google Scholar] [CrossRef] [PubMed]
[11] 宋先旭, 姜宏春, 张佳楠. 甲状腺全切术结合~(131)I清甲治疗甲状腺嗜酸性细胞肿瘤40例[J]. 中国现代普通外科进展, 2018, 21(9): 6.
[12] Pujol, P., Daures, J.P., Nsakala, N., et al. (1996) Degree of Thyrotropin Suppression as a Prognostic Determinant in Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology and Metabolism, 81, 4318-4323. [Google Scholar] [CrossRef] [PubMed]